Kristy Wonders

Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

Olivier Govaere, Simon Cockell, Dina Tiniakos et al. · Science Translational Medicine · 2020 · 454 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +16

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

Michèle Vacca, Ioannis Kamzolas, Lea Mørch Harder et al. · Nature Metabolism · 2024 · 229 citations · Full text

Medicine, Nutrition, Nutritional Sciences +17

Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

Yasaman Vali, Jenny Lee, Jérôme Boursier et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 196 citations · Full text

Medicine, Pathology, Diagnostic Pathology +16

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

Timothy Hardy, Kristy Wonders, Ramy Younes et al. · Contemporary Clinical Trials · 2020 · 133 citations · Full text

Medicine, Pathology, Clinical Epidemiology +16

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

Katherine Johnson, Peter Leary, Olivier Govaere et al. · JHEP Reports · 2021 · 46 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +16